Results for tag: "Aldurazyme"

Aldurazyme is a drug used to treat endocrine and metabolic disorders. It is a recombinant form of the enzyme laronidase, which is used to treat mucopolysaccharidosis type I (MPS I), a rare genetic disorder. Aldurazyme is administered intravenously and works by breaking down glycosaminoglycans, which are complex carbohydrates that accumulate in the body due to the lack of laronidase. The drug is approved for use in the United States, Europe, and other countries. Aldurazyme is marketed by Sanofi Genzyme, a subsidiary of Sanofi, and is available in the United States, Europe, and other countries. Other companies in the market include Shire, BioMarin Pharmaceuticals, and Ultragenyx Pharmaceuticals. Show Less Read more